Furthermore, it is antagonistic to insulin in human target cells, increased in serum in obesity and, most strongly, in Type 2 diabetes and also upregulated in human liver biopsies from individuals with NAFLD/NASH [10]. The gene discussed is INS; the disease is obesity disorder.